Advances in Chronic Kidney Disease
Volume 17, Issue 1 , Pages 44-51 , January 2010

Gene-Gene and Gene-Environment Interactions in HIV-Associated Nephropathy: A Focus on the MYH9 Nephropathy Susceptibility Gene

  • Marina Núñez
    • ,
  • Anita M. Saran
    • ,
  • Barry I. Freedman

      Affiliations

    • Corresponding Author InformationAddress correspondence to Barry I. Freedman, MD, Department of Internal Medicine, Section on Nephrology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157-1053.

References 

  1. Rao TK, Filippone EJ, Nicastri AD, et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med. 1984;310:669–673
  2. Lucas GM, Eustace JA, Sozio S, et al. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS. 2004;18:541–546
  3. Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004;66:1145–1152
  4. Carbone L, D'Agati V, Cheng JT, et al. Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med. 1989;87:389–395
  5. Cantor ES, Kimmel PL, Bosch JP. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med. 1991;151:125–128
  6. Abbott KC, Hypolite I, Welch PG, et al. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: Patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol. 2001;14:377–383
  7. D'Agati V, Suh JI, Carbone L, et al. Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int. 1989;35:1358–1370
  8. Winston JA, Bruggeman LA, Ross MD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 2001;344:1979–1984
  9. Lucas GM, Lau B, Atta MG, et al. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008;197:1548–1557
  10. Berliner AR, Fine DM, Lucas GM, et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol. 2008;28:478–486
  11. Choi AI, Rodriguez RA, Bacchetti P, et al. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol. 2007;18:2968–2974
  12. United States Renal Data System, USRDS 2005Annual Data Report; Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005
  13. Ross MJ, Klotman PE. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol. 2002;13:2997–3004
  14. Lucas GM, Mehta SH, Atta MG, et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21:2435–2443
  15. Cohen SD, Kimmel PL. Renal biopsy is necessary for the diagnosis of HIV-associated renal diseases. Nat Clin Pract Nephrol. 2009;5:22–23
  16. Ahuja TS, Borucki M, Funtanilla M, et al. Is the prevalence of HIV-associated nephropathy decreasing?. Am J Nephrol. 1999;19:655–659
  17. Shahinian V, Rajaraman S, Borucki M, et al. Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am J Kidney Dis. 2000;35:884–888
  18. Gerntholtz TE, Goetsch SJ, Katz I. HIV-related nephropathy: A South African perspective. Kidney Int. 2006;69:1885–1891
  19. Williams DI, Williams DJ, Williams IG, et al. Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS. Sex Transm Infect. 1998;74:179–184
  20. Laradi A, Mallet A, Beaufils H, et al. HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Nephrologiques d'Ile de France. J Am Soc Nephrol. 1998;9:2327–2335
  21. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int. 1999;55:1036–1040
  22. Izzedine H, Wirden M, Launay-Vacher V. Viral load and HIV-associated nephropathy. N Engl J Med. 2005;353:1072–1074
  23. Post FA, Campbell LJ, Hamzah L, et al. Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis. 2008;46:1282–1289
  24. Atta MG, Gallant JE, Rahman MH, et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant. 2006;21:2809–2813
  25. Wali RK, Drachenberg CI, Papadimitriou JC, et al. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet. 1998;352:783–784
  26. Scialla JJ, Atta MG, Fine DM. Relapse of HIV-associated nephropathy after discontinuing highly active antiretroviral therapy. AIDS. 2007;21:263–264
  27. Kirchner JT. Resolution of renal failure after initiation of HAART: 3 cases and a discussion of the literature. AIDS Read. 2002;12:103–105
  28. Freedman BI, Soucie JM, Stone SM, et al. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis. 1999;34:254–258
  29. Bruggeman LA, Ross MD, Tanji N, et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol. 2000;11:2079–2087
  30. Eitner F, Cui Y, Hudkins KL, et al. Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease. J Am Soc Nephrol. 2000;11:856–867
  31. Huber TB, Reinhardt HC, Exner M, et al. Expression of functional CCR and CXCR chemokine receptors in podocytes. J Immunol. 2002;168:6244–6252
  32. Winston JA, Bruggeman LA, Ross MD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 2001;344:1979–1984
  33. Marras D, Bruggeman LA, Gao F, et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med. 2002;8:522–526
  34. D'Agati VD. Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts). Kidney Int. 2008;73:399–406
  35. Barisoni L, Kriz W, Mundel P, et al. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 1999;10:51–61
  36. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest. 1997;100:84–92
  37. Zhong J, Zuo Y, Ma J, et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int. 2005;68:1048–1060
  38. Dickie P, Roberts A, Uwiera R, et al. Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy. Virology. 2004;322:69–81
  39. Zuo Y, Matsusaka T, Zhong J, et al. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol. 2006;17:2832–2843
  40. Husain M, Gusella GL, Klotman ME, et al. HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol. 2002;13:1806–1815
  41. Sunamoto M, Husain M, He JC, et al. Critical role for Nef in HIV-1-induced podocyte dedifferentiation. Kidney Int. 2003;64:1695–1701
  42. Husain M, D'Agati VD, He JC, et al. HIV-1 Nef induces dedifferentiation of podocytes in vivo: A characteristic feature of HIVAN. AIDS. 2005;19:1975–1980
  43. He JC, Husain M, Sunamoto M, et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest. 2004;114:643–651
  44. Lu TC, He JC, Wang ZH, et al. HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J Biol Chem. 2008;283:8173–8182
  45. Cantor ES, Kimmel PL, Bosch JP. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med. 1991;151:125–128
  46. Nochy D, Glotz D, Dosquet P, et al. Renal disease associated with HIV infection: A multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant. 1993;8:11–19
  47. Nochy D, Glotz D, Dosquet P, et al. Renal lesions associated with human immunodeficiency virus infection: North American vs. European experience. Adv Nephrol Necker Hosp. 1993;22:269–286
  48. Cohen SD, Kimmel PL. HIV-associated renal diseases in Africa a desperate need for additional study. Nephrol Dial Transplant. 2007;22:2116–2119
  49. Freedman BI, Spray BJ, Tuttle AB, et al. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis. 1993;21:387–393
  50. Freedman BI. Suseptibility genes for hypertension and renal failure. J Am Soc Nephrol. 2003;14:S192–S194
  51. Kopp JB, Smith MW, Nelson GW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008;40:1175–1184
  52. Kao WH, Klag MJ, Meoni LA, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 2008;40:1185–1192
  53. Freedman BI, Hicks PJ, Bostrom MA, et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int. 2009;75:736–745
  54. Gharavi AG, Ahmad T, Wong RD, et al. Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A. 2004;101:2488–2493
  55. Papeta N, Chan KT, Prakash S, et al. Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression. J Clin Invest. 2009;119:1178–1188
  56. Pecci A, Malara A, Badalucco S, et al. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation. Thromb Haemost. 2009;102:90–96
  57. Straus SE. Human herpesvirus-6 and -7. Principles and Practice of Infectious Diseases. Philadelphia: Elsevier; 2005;pp 1821-1825
  58. Crumpacker C, Wadhwa S. Cytomegalovirus. Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier; 2005;pp 1786-1800
  59. Blattner W, Charurat M. Human T-cell lymphotropic virus types l and ll. Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier; 2005;pp 2098-2118
  60. Sebekova K, Feber J, Carpenter B, et al. Tissue viral DNA is associated with chronic allograft nephropathy. Pediatr Transplant. 2005;9:598–603
  61. Demeter LM. JC, BK, and other polyomaviruses: Progressive multifocal leukoencephalopathy. Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier; 2005;
  62. Zhong S, Zheng HY, Suzuki M, et al. Age-related urinary excretion of BK polyomavirus by nonimmunocompromised individuals. J Clin Microbiol. 2007;45:193–198
  63. Crum-Cianflone N, Quigley M, Utz G, et al. BK virus-associated renal failure among HIV patients. AIDS. 2007;21:1501–1502
  64. Tsui JI, Vittinghoff E, Shlipak MG, et al. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med. 2007;167:1271–1276

 Supported in part by NIH grants RO1 DK 070941 (BIF) and RO1DK084149 (BIF).

PII: S1548-5595(09)00157-8

doi: 10.1053/j.ackd.2009.08.002

Advances in Chronic Kidney Disease
Volume 17, Issue 1 , Pages 44-51 , January 2010

Article Tools

* Image Usage & Resolution